Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
611.4 GBX | -0.10% | -4.17% | -4.77% |
Sales 2022 | -13.58M -16.92M | Sales 2023 | 10.47M 13.04M | Capitalization | 253M 315M |
---|---|---|---|---|---|
Net income 2022 | -22M -27.4M | Net income 2023 | 6M 7.47M | EV / Sales 2022 | -22.5 x |
Net Debt 2022 | 39.98M 49.79M | Net Debt 2023 | 32.47M 40.45M | EV / Sales 2023 | 27.3 x |
P/E ratio 2022 |
-11.9
x | P/E ratio 2023 |
38.4
x | Employees | - |
Yield 2022 |
4.83% | Yield 2023 |
4.38% | Free-Float | 90.88% |
Latest transcript on International Biotechnology Trust plc
1 day | -0.10% | ||
1 week | -4.17% | ||
Current month | -6.80% | ||
1 month | -5.36% | ||
3 months | -2.96% | ||
6 months | +1.56% | ||
Current year | -4.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | 47 | - | |
Jonathan Mott
CMP | Compliance Officer | - | - |
Lucy Duarte
IRC | Investor Relations Contact | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 20-05-18 | |
Gillian Elcock
BRD | Director/Board Member | 51 | 23-01-31 |
Director/Board Member | 59 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 611.4 | -0.10% | 12 054 |
24-04-18 | 612 | -1.45% | 41,845 |
24-04-17 | 621 | -0.96% | 47,156 |
24-04-16 | 627 | -0.63% | 101,079 |
24-04-15 | 631 | -1.10% | 63,847 |
Delayed Quote London S.E., April 19, 2024 at 07:34 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.77% | 289M | |
-0.62% | 14.16B | |
+0.26% | 6.1B | |
+9.25% | 4.35B | |
+7.72% | 4.28B | |
-9.64% | 3.89B | |
-3.30% | 3.29B | |
+8.05% | 3.19B | |
+4.53% | 3.03B | |
+8.58% | 2.71B |
- Stock Market
- Equities
- IBT Stock